Clinical trial
A Randomized, Controlled Trial of Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Airway Pressure Using the Infant Flow Advance to Facilitate Successful Extubation in Premature Infants.
NCT00188968 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled Trial of Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Airway Pressure Using the Infant Flow Advance to Facilitate Successful Extubation in Premature Infants.
- Lead sponsor
- University of Manitoba
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- February 28, 2007
- Enrollment
- 48 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
apnea, bronchopulmonary dysplasia, infant, premature